Sign in Pull a receipt

VRTX

VERTEX PHARMACEUTICALS INC / MA

Health Care · Biotechnology

$242.84 sample

-2.09 (-0.85%) 1D

Market cap

$1.29T

Price as of

2026-10-29

Latest filing

8-K · 2026-10-20

Alerts

8

Price$242.84 -7.25% 3M daily closessample

265.19229.16

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27INSInsider sell: Director
Oct 20SEC8-K filed: material event
Oct 09INSInsider sell: Director
Oct 06INSInsider buy: General Counsel
Sep 28INSInsider buy: Chief Financial Officer
Sep 23SEC10-Q filed
Sep 15INSInsider sell: 10% owner
Sep 09INSInsider sell: General Counsel

Sign up to see the real VRTX record →

Company facts

SEC EDGAR registration

Name: VERTEX PHARMACEUTICALS INC / MA
Sector: Health Care
Industry: Biotechnology
Smart-money score: -23sample, -100 to +100
Reporting currency: USD

Who is positioning in VRTX

sample

Insiders: 7 insider transactions over 90 days, net selling, $657.7M
Congress: 3 members traded over 90 days
Institutions · 13F: 32 funds hold $14.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$50.2B +9.6% y/y

Q4 2024Q3 2026

Inventory$31.6B +13.6% y/y

Q4 2024Q3 2026

Accounts receivable$22.8B +12.8% y/y

Q4 2024Q3 2026

Total debt$62.4B +16.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $966.0B -1.3% 3M
Sample peer B: $291.1B +13.4% 3M
Sample peer C: $1.08T +3.4% 3M
Sample peer D: $943.1B +6.3% 3M
Sample peer E: $807.6B -11.6% 3M